Evidence map›Paper›PMID 42281923›Full record

ArticleInternational journal of nanomedicine2026

Glucose-Responsive Dual-Enzyme Mimetic Nanoreactor Remodels Diabetic Periodontitis Microenvironment for Augmented Alveolar Bone Regeneration.

Dai Wang, Jianzhao Chen, Junjie Wang, Haojie Chen, Wenqiang Li, Shan Shen

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dai Wang *School of Stomatology, Jinan University, Guangzhou, Guangdong, People's Republic of China.ORCID 0009-0005-0745-8764
Jianzhao Chen *School of Stomatology, Jinan University, Guangzhou, Guangdong, People's Republic of China.ORCID 0009-0005-6746-9430
Junjie Wang *Hospital of Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China.
Haojie ChenSchool of Stomatology, Jinan University, Guangzhou, Guangdong, People's Republic of China.ORCID 0009-0003-8653-2613
Wenqiang LiGuangdong Traditional Medical and Sports Injury Rehabilitation Research Institute, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0002-1498-2258
Shan ShenHospital of Stomatology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0001-7981-8224

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Periodontitis in the context of diabetes severely disrupts bone metabolic homeostasis, leading to irreversible alveolar bone loss. The resulting alveolar bone defects face significant challenges in healing due to a pathological microenvironment characterized by the interplay of hyperglycemia, oxidative stress, infection, and inflammation. Existing therapeutic strategies often lack the capability to synchronously and intelligently regulate this complex milieu, resulting in delayed and inefficient bone repair. Methods: A composite material, termed MTS@QP-G@CO, was developed. Its core consists of manganese dioxide (MnO Results: The MTS@QP-G@CO designed sequential action at the defect site involves triggering a "glucose starvation" effect via glucose oxidase, followed by hydrogen peroxide decomposition and oxygen generation catalyzed by the MnO Conclusion: The MTS@QP-G@CO system effectively reverses the pathological microenvironment, coordinates immune modulation and osteogenesis, and transforms delayed healing into efficient, high-quality bone regeneration, offering a promising therapeutic approach for diabetes-related bone defects.

Indexed as

Bone RegenerationPeriodontitisAlveolar Bone LossAnimalsAnti-Bacterial AgentsCell DifferentiationCellular MicroenvironmentDiabetes Mellitus, ExperimentalGlucoseGlucose OxidaseHydrogelsManganese CompoundsMiceOsteogenesisOxidesRAW 264.7 CellsAnti-Bacterial AgentsGlucoseGlucose OxidaseHydrogelsManganese Compoundsmanganese dioxideOxidesTanninscascade reactionenzyme activitymacrophage polarizationosteogenic differentiation

Identifiers

PMID42281923
PMCPMC13250248

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.